 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | Medical Research Council Unit-The Gambia |
| Street 1: | Fajara |
| Street 2: | |
| City: | Banjul |
| Province: | |
| Post Code: | PO Box 273 |
| Country: | Gambia |
| Phone: | (+220) 4495442/6 |
| Organization Email: | hr@mrc.gm |
| Web Site: | http://www.mrc.gm |
| Other Online Presence: | |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | Technical agencies |
| Is your organization legally registered in your country: | Yes |
| If yes, please enter your registration number: | |
| Organization Type - Primary: | Academic / Research Institution |
| Organization Type - Secondary: | None |
| Organization Description: | |
| Established in The Gambia in 1947, the MRC is the UK ’s single largest investment in medical research in a developing country. The Unit’s research focuses on infectious diseases of immediate concern to The Gambia and the continent of Africa, with the aim of reducing the burden of illness and death in the country and the developing world as a whole. Tuberculosis represents an area of longstanding research in the Gambia with both community as well as laboratory research, headed by the Themeleader in Vaccinology, A/Profressor Beate Kampmann. |
|
| Do you know about the UNHLM declaration: | |
Specializations / Areas of Work | |
|
Advocacy Delivery of health services and care Funding, including innovative and optimized approach to funding TB Care Provision of drugs, diagnostics and commodities Research and Development Technical Assistance |
Other Organization Information | |
| Total number of staff in your organization: | 100 + |
| Number of full-time staff who are directly involved with TB: | 26 - 50 |
| Number of part-time staff who are directly involved with TB: | 11 - 25 |
| Number of volunteers who are directly involved with TB: | 6 - 10 |
| How did you hear about the Stop TB Partnership: | Stop TB communications |
| If you were informed or referred by another partner of the Stop TB Partnership please tell us who: | |
| Why do you wish join the Stop TB Partnership: | Network with other partners |
| Are you a member of a Stop TB national partnership: | No |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| We hold several grants in collaboration with the NLTP of the Gambia, incl Global Fund and TB Reach. We work in an integarted fashion and provide laboratory support in both trainign and diagnostics, incl. DST to the NLTP. | |
Geographical Reach | |
| Which country is your headquarters located in: | Gambia |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
Gambia |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
TB Care Delivery: active case finding and manahgement Drug-Resistant TB: laboratory capacity for DST TB-HIV: monitoring of co-infection Laboratory Strengthening: reference lab for TB New Diagnostics: research programs for adults and childrne New TB Vaccines: research programs for biomarkers/immunogenicity read-outs/fiunctional bactericidal assays Fundamental Research: immune responses and biomarkes at various ages and stages of disease Research: tuberculin survey, use of digitalised X rays |
|
Declaration | |
| Declaration of interests: no conflict of interest | |
| Application date: | February 8, 2011 |
| Last updated: | July 20, 2013 |